1[1]Satterlee W, Beasley C, Sanger T, et al. Olanzapine, a new "atypical” antipsychotic [J]. Schizophr Res, 1995, 15(1-2):163.
2[2]Beasley CM, Tollefson GD, Tran PV. Efficacy of olanzapine: An overview of pivotal clinical trials [J]. J Clin Psychiatry, 1997, 58(Suppl.10):7.
3[3]Chakrabarti JK, Hotten TM, Tupper DE. 2-Methyl thienobenzodiazepine [P]. EP: 454436, 1991-10-30; US:5229382, 1993-07-20. (CA 1991, 116:83703u)
4CHARLES M B, DNIEL E C, ROBERT W K. Olanzapine: a new atypical antipsychotie[J]. J Clin Psychiatry Monograph, 1998,16(1) :35-47.
5SHASTRL J A, JOHN R N, SUSAN M R, et al. A process for producing pure form of 2-methyl-4-(4-methyl-l-piperazinyl)-10H-thieno [ 2, 3-b ] [1, 5] benzodiazepine: WO, 2006006180[P]. 2006-01-19.
6CHAKRABARTI J K, HOTTEN T M, TUPPER D E. 2- Methylthienobenzodiazepine: EP, 454436[P]. 1991-10-30.
7KELTJENS R, THEODORS H A. Synthesis of Olanzapine and intermediates therefore: USA, 2005/0267099[P]. 2005-12-01.
